IBDEI0P2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11184,0)
 ;;=M35.01^^77^726^2
 ;;^UTILITY(U,$J,358.3,11184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11184,1,3,0)
 ;;=3^Sicca Syndrome w/ Keratoconjunctivitis
 ;;^UTILITY(U,$J,358.3,11184,1,4,0)
 ;;=4^M35.01
 ;;^UTILITY(U,$J,358.3,11184,2)
 ;;=^5011787
 ;;^UTILITY(U,$J,358.3,11185,0)
 ;;=H10.503^^77^726^3
 ;;^UTILITY(U,$J,358.3,11185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11185,1,3,0)
 ;;=3^Blepharoconjunctivitis,Bilateral
 ;;^UTILITY(U,$J,358.3,11185,1,4,0)
 ;;=4^H10.503
 ;;^UTILITY(U,$J,358.3,11185,2)
 ;;=^5004699
 ;;^UTILITY(U,$J,358.3,11186,0)
 ;;=H01.001^^77^726^4
 ;;^UTILITY(U,$J,358.3,11186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11186,1,3,0)
 ;;=3^Blepharitis,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,11186,1,4,0)
 ;;=4^H01.001
 ;;^UTILITY(U,$J,358.3,11186,2)
 ;;=^5004238
 ;;^UTILITY(U,$J,358.3,11187,0)
 ;;=H01.004^^77^726^5
 ;;^UTILITY(U,$J,358.3,11187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11187,1,3,0)
 ;;=3^Blepharitis,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,11187,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,11187,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,11188,0)
 ;;=L71.9^^77^726^6
 ;;^UTILITY(U,$J,358.3,11188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11188,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,11188,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,11188,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,11189,0)
 ;;=H04.221^^77^726^10
 ;;^UTILITY(U,$J,358.3,11189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11189,1,3,0)
 ;;=3^Epiphora d/t Insuff Drainage,Right 
 ;;^UTILITY(U,$J,358.3,11189,1,4,0)
 ;;=4^H04.221
 ;;^UTILITY(U,$J,358.3,11189,2)
 ;;=^5004491
 ;;^UTILITY(U,$J,358.3,11190,0)
 ;;=H04.222^^77^726^11
 ;;^UTILITY(U,$J,358.3,11190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11190,1,3,0)
 ;;=3^Epiphora d/t Insuff Drainage,Left 
 ;;^UTILITY(U,$J,358.3,11190,1,4,0)
 ;;=4^H04.222
 ;;^UTILITY(U,$J,358.3,11190,2)
 ;;=^5004492
 ;;^UTILITY(U,$J,358.3,11191,0)
 ;;=H04.551^^77^726^12
 ;;^UTILITY(U,$J,358.3,11191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11191,1,3,0)
 ;;=3^Acquired Stenosis,Right Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,11191,1,4,0)
 ;;=4^H04.551
 ;;^UTILITY(U,$J,358.3,11191,2)
 ;;=^5004538
 ;;^UTILITY(U,$J,358.3,11192,0)
 ;;=H04.552^^77^726^13
 ;;^UTILITY(U,$J,358.3,11192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11192,1,3,0)
 ;;=3^Acquired Stenosis,Left Nasolacrimal Duct
 ;;^UTILITY(U,$J,358.3,11192,1,4,0)
 ;;=4^H04.552
 ;;^UTILITY(U,$J,358.3,11192,2)
 ;;=^5004539
 ;;^UTILITY(U,$J,358.3,11193,0)
 ;;=H04.211^^77^726^7
 ;;^UTILITY(U,$J,358.3,11193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11193,1,3,0)
 ;;=3^Epiphora d/t Excessive Lacrimation,Right
 ;;^UTILITY(U,$J,358.3,11193,1,4,0)
 ;;=4^H04.211
 ;;^UTILITY(U,$J,358.3,11193,2)
 ;;=^5004487
 ;;^UTILITY(U,$J,358.3,11194,0)
 ;;=H04.212^^77^726^8
 ;;^UTILITY(U,$J,358.3,11194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11194,1,3,0)
 ;;=3^Epiphora d/t Excessive Lacrimation,Left
 ;;^UTILITY(U,$J,358.3,11194,1,4,0)
 ;;=4^H04.212
 ;;^UTILITY(U,$J,358.3,11194,2)
 ;;=^5004488
 ;;^UTILITY(U,$J,358.3,11195,0)
 ;;=H04.213^^77^726^9
 ;;^UTILITY(U,$J,358.3,11195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11195,1,3,0)
 ;;=3^Epiphora d/t Excessive Lacrimation,Bilateral
 ;;^UTILITY(U,$J,358.3,11195,1,4,0)
 ;;=4^H04.213
 ;;^UTILITY(U,$J,358.3,11195,2)
 ;;=^5004489
 ;;^UTILITY(U,$J,358.3,11196,0)
 ;;=D23.111^^77^726^14
